Why the study?
Does ICD implantation reduce all-cause mortality in patients with non-ischemic cardiomyopathy?
Does ICD implantation reduce all-cause mortality in patients with non-ischemic cardiomyopathy?
While ICDs do not reduce overall all-cause mortality in non-ischemic cardiomyopathy, they significantly reduce mortality and sudden cardiac death in patients under 68 years of age.
Does not support routine ICD use in non-ischemic cardiomyopathy; leaves open age-specific benefit under 68 years.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Kim et al. (2017) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: